BONOMINI, Mario
 Distribuzione geografica
Continente #
EU - Europa 1.629
NA - Nord America 300
AS - Asia 177
AF - Africa 17
SA - Sud America 7
Totale 2.130
Nazione #
IT - Italia 1.268
US - Stati Uniti d'America 281
SE - Svezia 173
VN - Vietnam 71
IE - Irlanda 51
DE - Germania 33
TR - Turchia 24
CN - Cina 21
IN - India 18
FR - Francia 17
CA - Canada 11
CH - Svizzera 11
GB - Regno Unito 10
RU - Federazione Russa 10
CZ - Repubblica Ceca 7
IQ - Iraq 7
MX - Messico 6
NL - Olanda 6
DK - Danimarca 5
DZ - Algeria 5
ES - Italia 5
MY - Malesia 5
SG - Singapore 5
UA - Ucraina 5
AR - Argentina 4
HU - Ungheria 4
IL - Israele 4
PT - Portogallo 4
RS - Serbia 4
JP - Giappone 3
LT - Lituania 3
NG - Nigeria 3
PL - Polonia 3
TH - Thailandia 3
BE - Belgio 2
BO - Bolivia 2
BS - Bahamas 2
EG - Egitto 2
FI - Finlandia 2
GR - Grecia 2
ID - Indonesia 2
JO - Giordania 2
KR - Corea 2
LK - Sri Lanka 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
CM - Camerun 1
CV - Capo Verde 1
GM - Gambi 1
LI - Liechtenstein 1
LY - Libia 1
MA - Marocco 1
MK - Macedonia 1
SD - Sudan 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZM - Zambia 1
Totale 2.130
Città #
Chieti 289
Stockholm 172
Dong Ket 70
Dublin 50
Ashburn 43
Milan 41
Rome 31
Vittuone 31
Boardman 25
Fleming Island 17
Florence 14
Livorno 14
Bologna 12
Chandler 11
Lanciano 11
Torino 11
Bari 10
Genova 10
Kahramanmaraş 10
Naples 10
Dallas 9
Houston 9
San Jose 9
Brescia 8
Chennai 8
Wuhan 8
Ann Arbor 7
Pisa 7
Trieste 7
Ferrara 6
Istanbul 6
Latina 6
Napoli 5
Palermo 5
Ankara 4
Beijing 4
Brooklyn 4
Civitanova Marche 4
Guardiagrele 4
Pescara 4
Sassari 4
Wilmington 4
Abuja 3
Avezzano 3
Belgrade 3
Bozzolo 3
Buffalo 3
Carugo 3
Castelfranco Veneto 3
Catania 3
Como 3
Corgemont 3
Forlì 3
Kaunas 3
Kiev 3
La Spezia 3
London 3
Malo 3
Mountain View 3
Perugia 3
Reggio Nell'emilia 3
Rivalta di Torino 3
San Diego 3
San Giovanni La Punta 3
Santa Clara 3
Tlemcen 3
Turin 3
Venezia 3
Vigevano 3
Zurich 3
Altissimo 2
Anzio 2
Baghdad 2
Bangkok 2
Barcelona 2
Bergamo 2
Busto Arsizio 2
Cagliari 2
Camparada 2
Capannori 2
Castel 2
Castelnuovo Di Porto 2
Cornigliano 2
Cosenza 2
Council Bluffs 2
Crema 2
Crispiano 2
Desio 2
Divignano 2
Divulapitiya 2
Federal 2
Ferentino 2
Fermo 2
Foggia 2
Fremont 2
Guangzhou 2
Hanover 2
Helsinki 2
Hyderabad 2
Incheon 2
Totale 1.158
Nome #
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy, file e4233f17-4bea-2860-e053-6605fe0a460a 568
Use of oral hypoglycemic agents in patients with chronic kidney failure, file e4233f14-f92c-2860-e053-6605fe0a460a 244
null, file e4233f19-6877-2860-e053-6605fe0a460a 92
Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations, file e4233f17-b9aa-2860-e053-6605fe0a460a 73
A Novel Formulation of Glucose-Sparing Peritoneal Dialysis Solutions with l-Carnitine Improves Biocompatibility on Human Mesothelial Cells, file e4233f18-3230-2860-e053-6605fe0a460a 67
Uremic toxicity and anemia, file e4233f16-a902-2860-e053-6605fe0a460a 61
Extra-hepatic manifestations associated with Hepatitis and virus infection, file e4233f16-db6b-2860-e053-6605fe0a460a 44
Therapy of glucocorticoid induced osteoporosis, file e4233f16-df2e-2860-e053-6605fe0a460a 41
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure, file e4233f16-2523-2860-e053-6605fe0a460a 38
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy, file e4233f17-d609-2860-e053-6605fe0a460a 33
Effect of erythropoietin on primed leucocyte expression profile., file e4233f15-bd24-2860-e053-6605fe0a460a 28
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells, file e4233f15-dbec-2860-e053-6605fe0a460a 27
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression, file e4233f14-eb6b-2860-e053-6605fe0a460a 26
L-Carnitine is an osmotic agent suitable for peritoneal dialysis, file e4233f15-a44c-2860-e053-6605fe0a460a 26
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis, file e4233f18-bdb6-2860-e053-6605fe0a460a 26
Biological effects of XyloCore, a glucose sparing PD solution, on mesothelial cells: focus on mesothelial-mesenchymal transition, inflammation and angiogenesis, file e4233f18-ca30-2860-e053-6605fe0a460a 26
null, file e4233f16-2860-2860-e053-6605fe0a460a 25
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients, file e4233f19-7421-2860-e053-6605fe0a460a 25
Urinary Peptidomic Biomarkers in Kidney Diseases, file e4233f17-6925-2860-e053-6605fe0a460a 23
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells, file e4233f14-fa82-2860-e053-6605fe0a460a 21
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis., file e4233f17-8d05-2860-e053-6605fe0a460a 21
Proteomic Research in Peritoneal Dialysis, file e4233f17-cf17-2860-e053-6605fe0a460a 21
null, file e4233f17-f259-2860-e053-6605fe0a460a 21
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis, file e4233f17-49ed-2860-e053-6605fe0a460a 20
Removal of uremic plasma factors using different dialysis modalities, file e4233f16-a38e-2860-e053-6605fe0a460a 19
Quali soluzioni future per la dialisi peritoneale?, file e4233f18-9d75-2860-e053-6605fe0a460a 19
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy, file e4233f15-03cf-2860-e053-6605fe0a460a 17
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients, file e4233f15-a5f5-2860-e053-6605fe0a460a 17
Prognostic value of morphologic and morphometric analyses in IgA nephropathy biopsies, file e4233f16-1aec-2860-e053-6605fe0a460a 17
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression, file e4233f14-eb6c-2860-e053-6605fe0a460a 16
Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study, file e4233f18-bbd0-2860-e053-6605fe0a460a 16
Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis B infection: A case report, file bdd467b7-623d-48df-8556-c67cd18f1efe 14
A New Peritoneal Dialysis Solution Containing L‐Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience, file e4233f18-4d2d-2860-e053-6605fe0a460a 14
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study, file 8d96b337-4f84-4ef2-a13a-f7ab032755c0 13
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells, file e4233f14-ed38-2860-e053-6605fe0a460a 13
Plasma protein carbonylation in chronic uremia, file e4233f14-f8f8-2860-e053-6605fe0a460a 13
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis, file e4233f16-d6f0-2860-e053-6605fe0a460a 13
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs), file e4233f16-db0e-2860-e053-6605fe0a460a 13
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis, file e4233f18-6b54-2860-e053-6605fe0a460a 13
IgA Deficiency and Membranoproliferative Glomerulonephritis: A Case Report, file e4233f18-a0b4-2860-e053-6605fe0a460a 13
Post-dialysis fatigue and survival in patients on chronic hemodialysis, file e4233f18-bf50-2860-e053-6605fe0a460a 13
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation, file e4233f15-06c4-2860-e053-6605fe0a460a 12
Blood cell proteomics in chronic kidney disease, file e4233f16-e135-2860-e053-6605fe0a460a 11
New treatment approaches for the anemia of CKD, file e4233f16-2294-2860-e053-6605fe0a460a 10
Biocompatibility of DIAPES, file e4233f16-a38c-2860-e053-6605fe0a460a 10
null, file e4233f17-dd9a-2860-e053-6605fe0a460a 10
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey, file e4233f18-7115-2860-e053-6605fe0a460a 10
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy, file e4233f19-1f7b-2860-e053-6605fe0a460a 10
Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful?, file e4233f17-5f8d-2860-e053-6605fe0a460a 9
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis, file e4233f19-1874-2860-e053-6605fe0a460a 9
Efficacy of hemoperfusion with Seraph-100 in series with single pass albumin dialysis in acute hepatitis B infection: A case report, file 4354d950-6e41-4027-9dfd-4ce30a350b98 8
How to improve the biocompatibility of peritoneal dialysis solutions (without Jeopardizing the patient’s health), file e4233f18-b1f4-2860-e053-6605fe0a460a 8
Carnitine in metabolic disease: potential for pharmacological intervention, file e4233f14-ebf8-2860-e053-6605fe0a460a 7
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter, file e4233f15-c147-2860-e053-6605fe0a460a 7
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy, file e4233f18-e1ef-2860-e053-6605fe0a460a 7
The risks associated with percutaneous native kidney biopsies: a prospective study, file 4eba164d-a274-4172-9102-28637484ea24 6
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia, file e4233f14-ebf7-2860-e053-6605fe0a460a 6
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations, file e4233f15-1456-2860-e053-6605fe0a460a 6
Update sull'impiego della proteomica in emodialisi, file e4233f16-285d-2860-e053-6605fe0a460a 6
Prevalence and severity of postdialysis fatigue are higher in patients on chronic hemodialysis with functional disability, file e4233f16-fe04-2860-e053-6605fe0a460a 6
Proteomics and nephrology, file e4233f14-ff70-2860-e053-6605fe0a460a 5
Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells., file e4233f16-a356-2860-e053-6605fe0a460a 5
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations, file e4233f17-83a2-2860-e053-6605fe0a460a 5
Treatment options for anemia in kidney transplant patients: a review, file f0a8f9ab-0ad5-4610-b217-bdcd305e2907 5
Proteomics characterization of protein adsorption onto hemodialysis membranes, file e4233f14-eb29-2860-e053-6605fe0a460a 4
Dialysis practice and patient outcome in the aftermath of the earthquake at L'Aquila, Italy, April 2009, file e4233f14-f814-2860-e053-6605fe0a460a 4
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial., file e4233f15-0503-2860-e053-6605fe0a460a 4
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation., file e4233f15-06f1-2860-e053-6605fe0a460a 4
Prevalence and associated variables of postdialysis fatigue: results of a prospective multicenter study, file e4233f16-df28-2860-e053-6605fe0a460a 4
Successful use of single-pass albumin dialysis in the correction of severe hyperbilirubinemia in a case of acute hepatitis E, file e4abbc96-6e74-4cfb-a1d9-d4e5731beb8e 4
Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review, file 1d64ec33-5de0-4ca3-b18d-1e5e2e4ae9e7 3
Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study, file 6e21677d-aba9-4243-96a0-acc0f6eee8d2 3
Rare Single Nucleotide and Copy Number Variants and the Etiology of Congenital Obstructive Uropathy: Implications for Genetic Diagnosis, file 6f40da36-7ba2-4022-8b49-d075cf926451 3
null, file b600a37d-dd9b-4cbe-9b21-5e4e08674875 3
Dialysis practice and patient outcome in the aftermath of the earthquake at L'Aquila, Italy, April 2009, file e4233f14-f813-2860-e053-6605fe0a460a 3
Management of IgA nephropathy, file e4233f14-f81a-2860-e053-6605fe0a460a 3
null, file e4233f16-25c5-2860-e053-6605fe0a460a 3
Examining hemodialyzer membrane performance using proteomic technologies, file e4233f16-899b-2860-e053-6605fe0a460a 3
Defining the potential antidepressant mode of action of acetyl-l-carnitine., file e4233f16-db70-2860-e053-6605fe0a460a 3
Valutazione psicologica del paziente in trattamento dialitico cronico: comparazione tra tecniche sostitutive domiciliari e ospedaliere, file e4233f18-b7d1-2860-e053-6605fe0a460a 3
Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis, file e4233f18-e262-2860-e053-6605fe0a460a 3
Alterazioni eritrocitarie e loro possibile ruolo nelle complicanze cardiovascolari dell’uremia, file 492dbd4f-aea2-4827-b6e2-d40e7fe70ace 2
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia, file e4233f14-ebf6-2860-e053-6605fe0a460a 2
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine, file e4233f14-ebfd-2860-e053-6605fe0a460a 2
Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine, file e4233f14-ebfe-2860-e053-6605fe0a460a 2
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable?, file e4233f14-f816-2860-e053-6605fe0a460a 2
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici], file e4233f14-f817-2860-e053-6605fe0a460a 2
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?, file e4233f14-f926-2860-e053-6605fe0a460a 2
Serum fetuin-a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?, file e4233f14-f927-2860-e053-6605fe0a460a 2
Leukapheresis and chronic inflammatory bowel disease: an additional obligation for the nephrologist, file e4233f14-fefe-2860-e053-6605fe0a460a 2
Prognosis of CKD patients receiving outpatient nephrology care in Italy, file e4233f14-ff02-2860-e053-6605fe0a460a 2
Proteomic Investigations into Hemodialysis Therapy, file e4233f15-49a9-2860-e053-6605fe0a460a 2
Increased erythrocyte phosphatidylserine exposure in chronic renal failure, file e4233f16-2a68-2860-e053-6605fe0a460a 2
Epatotossicità acuta da amiodarone endovena in una paziente in emodialisi, file e4233f16-2b56-2860-e053-6605fe0a460a 2
Proteomics and protein adsorption on hemodialysis membranes, file e4233f16-8b36-2860-e053-6605fe0a460a 2
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander?, file e4233f16-aae5-2860-e053-6605fe0a460a 2
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests, file e4233f16-abf9-2860-e053-6605fe0a460a 2
Glomerulopathies associated with psoriasis: a report of three cases, file e4233f16-acdf-2860-e053-6605fe0a460a 2
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis, file e4233f16-ace1-2860-e053-6605fe0a460a 2
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate., file e4233f16-fa64-2860-e053-6605fe0a460a 2
Totale 2.123
Categoria #
all - tutte 14.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.722


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 3 0 0 2 3 1 3 0
2019/202084 5 2 2 3 0 0 0 0 22 39 7 4
2020/2021600 6 4 46 79 69 60 61 66 38 39 38 94
2021/2022450 29 24 51 35 46 22 19 34 31 56 62 41
2022/2023863 67 53 45 44 66 111 148 64 51 64 113 37
2023/2024100 40 35 25 0 0 0 0 0 0 0 0 0
Totale 2.148